The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chanda Sanjay since 2014.
This trader's CIK number is 1571820.
At the time of last reporting, Chanda Sanjay was the Chief Development Officer of An2 Therapeutics, Inc.. (stock ticker symbol ANTX).
Also see all insider trading activities at An2 Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ANTX | 0 | $0 | 2,957 | $3,965 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ANAC | 0 | $0 | 5,000 | $225,000 | 5,000 | $37,000 |
| 2014 | ANAC | 0 | $0 | 15,000 | $417,500 | 34,073 | $216,801 |
1. An2 Therapeutics, Inc. (ANTX)
2. Anacor Pharmaceuticals Inc (ANAC)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-03 | ANTX | Sale | 2,957 | 1.34 | 3,965 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-04 | ANAC | Sale | 5,000 | 45.00 | 225,000 |
| 2015-03-04 | ANAC | Option Ex | 5,000 | 7.40 | 37,000 |
| 2014-12-19 | ANAC | Option Ex | 19,073 | 6.25 | 119,301 |
| 2014-11-26 | ANAC | Sale | 5,000 | 35.00 | 175,000 |
| 2014-11-26 | ANAC | Option Ex | 5,000 | 7.25 | 36,250 |
| 2014-09-10 | ANAC | Sale | 10,000 | 24.25 | 242,500 |
| 2014-09-10 | ANAC | Option Ex | 10,000 | 6.12 | 61,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chanda Sanjay (Chief Development Officer of An2 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.